Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
07 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250606873555/en/Otsuka-Sibeprenlimab-Phase-3-Data-Show-a-Statistically-Significant-and-Clinically-Meaningful-Proteinuria-Reduction-for-the-Treatment-of-Immunoglobulin-A-Nephropathy-IgAN
04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093972/0/en/Vera-Therapeutics-to-Participate-in-the-Goldman-Sachs-46th-Annual-Global-Healthcare-Conference.html
03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3092556/0/en/Vera-Therapeutics-Announces-Refinancing-of-Existing-Oxford-Debt-Facility-Providing-up-to-500-Million-of-Term-Loans.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3091685/0/en/Vera-Therapeutics-Announces-Atacicept-Achieved-46-Proteinuria-Reduction-in-ORIGIN-Phase-3-Trial-in-Adults-with-IgA-Nephropathy.html
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078525/0/en/Vera-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074962/0/en/Vera-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2025-Financial-Results.html
ABOUT THIS PAGE